Back to mobile site

Orexigen (OREX) Shares Surge Ahead of FDA Response for Contrave NDA

January 31, 2011 2:14 PM EST Send to a Friend
Shares of Orexigen (Nasdaq: OREX) have risen sharply today as the company's PFUDA date for its NDA of Contrave is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login